Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study).
Otten
J
J
A. Z. K.-V. U. B., Brussels, Belgium.
Flamant
F
F
Rodary
C
C
Brunat-Mentigny
M
M
Dutou
L
L
Olive
D
D
Quintana
E
E
Voûte
P A
PA
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D003609:Dactinomycin / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008637:Mesenchymoma / Q000188:drug therapy*; D012208:Rhabdomyosarcoma / Q000188:drug therapy*; D014750:Vincristine / Q000008:administration & dosage
D003609:Dactinomycin; D014750:Vincristine; D007069:Ifosfamide